摘要
膀胱癌是泌尿生殖系常见的恶性肿瘤之一,是一种直接威胁患者生存的疾病。经尿道膀胱肿瘤切除术既是非肌层浸润性膀胱癌的重要诊断方法,同时也是主要的治疗方案。单纯的经尿道膀胱肿瘤切除术后存在较高的肿瘤复发率与疾病进展率,故术后行膀胱灌注治疗能在一定程度上降低膀胱肿瘤复发与进展。研究者们针对膀胱灌注治疗药物、治疗方案的选择等进行了大量研究,旨在更好地提高灌注疗效,降低肿瘤复发,延缓疾病进展。现就近年来非肌层浸润性膀胱癌膀胱灌注治疗的新进展予以阐述与总结。
Bladder cancer is one of the common malignant tumors in urogenital system, and it is a disease that directly threatens the patients＇ survival. Transurethral resection of bladder tumor is an important method for diagnosis and treatment of bladder carcinoma. However, there is a high recurrence rate and the disease progression rate after transurethral resection of bladder tumor. Postoperative bladder instillation may play a role in control the recurrence and progress of bladder tumor. The researchers have studied on the selection of drugs and treatment options for bladder instillation in order to improve the efficacy, reduce tumor recurrence, and delay the progression of the disease. This paper summarized the new development of bladder instillation for non-muscle-invasive bladder cancer in recent years.
出处
《临床泌尿外科杂志》
2016年第2期180-184,共5页
Journal of Clinical Urology
关键词
膀胱肿瘤
灌注治疗
药物疗法
bladder tumor
instillation therapy
drug therapy
